6 Potential Benefits of Psilocybin Containing Mushrooms

 
 

Psilocybin, with its deep-rooted history of use in indigenous cultures, is now the subject of modern scientific exploration. Recent research has shown that psilocybin has several potential benefits.

Mental Health

One of the most exciting areas of research involves psychedelic-assisted therapies using psilocybin. Ever ongoing studies have shown encouraging results in using psilocybin-assisted therapy to address treatment-resistant depression, anxiety, and post-traumatic stress disorder (PTSD). The psychedelic experience induced by psilocybin allows patients to gain profound insights, process emotions, and confront underlying traumas, significantly improving mental health outcomes. 

Therapeutic sessions often include supportive psychotherapy models both before and after the psychedelic experience to maximise the therapeutic benefits. The research also suggests mushrooms may improve mood, increase well-being, and enhance emotional processing. 

The effects of psilocybin become apparent shortly after administration, typically within a matter of days, which is very much in contrast to standard antidepressants, which may require several weeks to take full effect. Moreover, the antidepressant benefits of psilocybin are studied to endure for an extended period, ranging from 4 weeks to as long as 6-12 months.

Physical Health

Psilocybin is believed by some to be the safest of all recreational drugs. Microdosing and taking up to 1.5 grams of psilocybin has been shown to be an effective treatment for cluster headaches and migraines. More research is needed to identify the relationship between headaches and treatments involving psilocybin mushrooms. 

Small doses of psilocybin may also be a useful supplement for athletes because they can help sharpen mental focus and enter a flow state more easily. While mushrooms alone won’t get someone into better physical condition, which requires cultivating a healthy and active lifestyle.

The continuously growing body of research holds the potential to illuminate whether these once-stigmatized substances can genuinely alleviate physical distress or if their effects are akin to placebos. Additionally, there is a need for research that aims to investigate any potential long-term side effects.

End-of-Life Anxiety and Palliative Care

Psilocybin has also shown promise in reducing end-of-life anxiety in terminally ill patients. Studies have demonstrated that a single guided psilocybin session can substantially reduce anxiety and enhance the sense of peace and acceptance among patients facing life-threatening illnesses. This therapeutic approach may offer a unique opportunity for individuals to find meaning and transcendence during their final days, easing the burden of anxiety and fear.

A 2020 research study to investigate the prolonged effectiveness of psilocybin-assisted psychotherapy in patients with life-threatening cancer, showed the long-term durability effects, suggesting the possibility of benefits for palliative care models. Their findings indicated that 70–100% of participants reported experiencing positive life changes from this intervention, and anxiety and depression were significantly reduced in 60–80% of the individuals—a response rate comparable to the results observed 6.5 months after the initial psilocybin administration. The single moderate-dose intervention had the potential to alleviate existential distress even after 3.2 to 4.5 years following the psilocybin treatment. 

The authors wrote: “The psilocybin experience may have enabled participants to establish a new inner framework from which they could flexibly avail themselves of resources internally and in their environment to cope with life stressors, particularly stressors associated with their cancer diagnoses.”

Spiritual and Personal Growth

Psilocybin mushrooms have been used in various cultural and spiritual practices for centuries. Many individuals report profound mystical or spiritual experiences, increased feelings of connectedness, and a sense of transcendence or awe after taking larger doses of mushrooms. These experiences may contribute to personal growth, spiritual well-being, the ability to self-reflect more deeply, and a broader perspective on life.

Substance Use Disorders

Another area of exploration is the potential of psilocybin in treating addiction and substance use disorders, including tobacco and alcohol addiction. The research suggests that psilocybin may help individuals break free from addiction patterns by promoting self-reflection, increasing self-compassion, and fostering a sense of connectedness. The profound experiences induced by psilocybin may lead to shifts in mindset and behaviour, reducing cravings and increasing motivation to overcome addiction, supporting long-term recovery.

Cognitive Enhancement and Creativity

Beyond therapeutic applications, psilocybin is also being studied for its potential cognitive benefits. Some individuals report enhanced creativity, improved problem-solving abilities, and heightened cognitive flexibility. People typically experience heightened creativity a few days after a psychedelic experience rather than during the trip. While the mechanisms behind these effects are not fully understood and outcomes even contradictive, the research explores the possibility of psilocybin as a cognitive enhancer and performance optimiser.

Although studies offer promising insights, they are susceptible to experimental biases such as confirmation bias and placebo effects. This issue is particularly challenging in the context of microdosing, given that users comprise a self-selected group with optimistic expectations regarding the practice's outcomes. 

Conclusion

In conclusion, psilocybin, the naturally occurring psychedelic compound found in certain mushrooms, holds significant promise across various domains of human experience. However, it is crucial to conduct further studies and adhere to strict safety protocols to understand the long-term effects and appropriate applications of psilocybin fully. As public attitudes towards psychedelics evolve, embracing this research with an open mind may unlock a new frontier in mental health treatment, providing hope and relief to those who suffer from challenging conditions.


References:

American Migraine Foundation. (2023, January 19). Can psilocybin treat cluster headache? American Migraine Foundation. https://americanmigrainefoundation.org/resource-library/can-psilocybin-treat-cluster-headache/

ASM.org. (n.d.). Psilocybin and Mental Health: The Magic in the Mushrooms. ASM. https://asm.org/Articles/2023/February/Psilocybin-and-Mental-Health-The-Magic-in-the-Mush

Beckley Foundation. (2020, November 17). Psychedelics as Catalysts of Spiritual Development. The Beckley Foundation. https://www.beckleyfoundation.org/psychedelics-as-catalysts-of-spiritual-development

Bogadi, M., & Kaštelan, S. (2021). A potential effect of psilocybin on anxiety in neurotic personality structures in adolescents. Croatian Medical Journal, 62(5), 528–530. https://doi.org/10.3325/cmj.2021.62.528

Brennan, W., & Belser, A. (2022). Models of Psychedelic-Assisted Psychotherapy: A contemporary assessment and an Introduction to EMBARK, a transdiagnostic, Trans-Drug model. Frontiers in Psychology, 13. https://doi.org/10.3389/fpsyg.2022.866018

Borrell, B. (2023, June 22). The next big addiction treatment. The New York Times. https://www.nytimes.com/2022/03/31/well/mind/psilocybin-mushrooms-addiction-therapy.html

Farah, T. (2021, September 30). Can psychedelic drugs treat physical pain? Scientific American. https://www.scientificamerican.com/article/can-psychedelic-drugs-treat-physical-pain/

Coffey, R. (2021, April 19). Psilocybin Impairs Productive Creativity, At Least While Users Are ‘Stoned’ — Or So A New Study Suggests. Forbes. https://www.forbes.com/sites/rebeccacoffey/2021/04/19/psilocybin-impairs-productive-creativity-at-least-while-users-are-stoned---or-so-a-new-study-suggests/?sh=7b1700e7294c

Dy, K. (2021). Psychedelics and sports: Can they propel athletes to unprecedented pinnacles of ability? Psychedelic Spotlight. https://psychedelicspotlight.com/psychedelics-sports-athletes-athletic-performance/

Goldhill, O. (2022, August 24). Psilocybin shows promise for treating alcohol addiction, new study finds. Stat News. https://www.statnews.com/2022/08/24/psilocybin-shows-promise-for-treating-alcohol-addiction-study/

Nichols, D. E. (2020). Psilocybin: from ancient magic to modern medicine. The Journal of Antibiotics, 73(10), 679–686. https://doi.org/10.1038/s41429-020-0311-8

van der Meer PB, Fuentes JJ, Kaptein AA, Schoones JW, de Waal MM, Goudriaan AE, Kramers K, Schellekens A, Somers M, Bossong MG, Batalla A. (2023, February 9). Therapeutic effect of psilocybin in addiction: A systematic review. Front Psychiatry. 14:1134454. doi: 10.3389/fpsyt.2023.1134454.

Hu, J. C. (2023, June 22). Microdosing psychedelics has benefits, users say. Science isn’t convinced. Washington Post. https://www.washingtonpost.com/wellness/2023/06/22/microdosing-mushrooms-psychedelics-mental-health/

Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2022). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 36(4), 423-434. doi.org/10.1016/j.jad.2022.11.046

Jones, G., Lipson, J., & Nock, M. K. (2022). Associations between classic psychedelics and nicotine dependence in a nationally representative sample. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-14809-3

Mason, N. (2022, February 1). Psychedelic-Induced Creativity: Fact or Fiction? MIND Foundation. https://mind-foundation.org/psychedelic-induced-creativity/

Plesner, A. (2023, July 13). 7 ways psychedelics impact creative thinking. Proto Life. https://proto.life/2022/07/7-ways-psychedelics-impact-creative-thinking/

Pollan, M. (2012, April 22). How psychedelic drugs can help patients face death. The New York Times Magazine. https://www.nytimes.com/2012/04/22/magazine/how-psychedelic-drugs-can-help-patients-face-death.html

Silva, L. (2022, October 28). How can psilocybin affect mental health? Forbes Health. https://www.forbes.com/health/mind/psilocybin-mental-health-benefits/

Travers, M. (2023b, July 3). MDMA, Psilocybin, And Ketamine: 3 Psychedelics With Different Mental Health ‘Use Cases.’ Forbes. https://www.forbes.com/sites/traversmark/2023/07/03/mdma-psilocybin-and-ketamine-3-psychedelics-with-different-mental-health-use-cases/

UHBlog. (2022, May 15). “Magic Mushrooms,” Psilocybin and mental health. University Hospitals. https://www.uhhospitals.org/blog/articles/2022/05/magic-mushrooms-psilocybin-and-mental-health

Van Amsterdam, J., & Van Den Brink, W. (2022). The therapeutic potential of psilocybin: a systematic review. Expert Opinion on Drug Safety, 21(6), 833–840. https://doi.org/10.1080/14740338.2022.2047929

Walker-Journey, J. (2023). Want to try psychedelics in a clinical setting? 116 trials now recruiting volunteers (UPDATED). Psychedelic Spotlight. https://psychedelicspotlight.com/psychedelic-clinical-trials-recruiting-volunteers/

Whinkin, E., Opalka, M., Watters, C., Jaffe, A., & Aggarwal, S. (2023). Psilocybin in palliative care: an update. Current Geriatrics Reports, 12(2), 50–59. https://doi.org/10.1007/s13670-023-00383-7

 

Learn everything you need to know about magic (psilocybin-containing) mushrooms through our self-paced online course. 10+ hours of educational materials and conference recordings from industry experts from MAPS, ZENDO, CIIS, and more.

 
 
Previous
Previous

An Interview with Floris Wolswijk from Blossom

Next
Next

What’s The Afterglow Effect? An Interview with Neil Markey.